Day: August 7, 2023

TERRE HAUTE, Ind., Aug. 07, 2023 (GLOBE NEWSWIRE) — Hallador Energy Company (NASDAQ – HNRG) reports first half 2023 and second quarter net income of $39.0 million and $16.9 million, basic earnings per share of $1.18 and $0.51, operating cash flow of $44.2 million and $18.1 million, and adjusted EBITDA of $69.3 million and $35.3 million, all respectively.   Brent Bilsland, President and Chief Executive Officer, stated, “Record profitability and continued debt reduction has helped de-lever our balance sheet to less than 1.0 times EBITDA, which is a top priority for Hallador.  Our team was also successful in closing a $140 million credit agreement, increasing our liquidity to $56.9 million as of June 30, 2023.  Hallador Power completed its obligation of selling 100% of its output to Merom’s original owner and is now available...

Results from FIREFLY-1 demonstrate overall response rate (ORR) of 67% and clinical benefit rate (CBR) of 93% in 69 heavily pretreated Response Assessment Neuro-Oncology High-Grade Glioma (RANO-HGG) evaluable patients presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting Initiated rolling submission of the tovorafenib New Drug Application (NDA) in relapsed or progressive pediatric low-grade glioma (pLGG) in May 2023 The Company expects to complete the rolling submission of the tovorafenib NDA by October 2023 Completed $172.5 million public offering, strengthening balance sheet and extending cash runway into 2026 BRISBANE, Calif., Aug. 07, 2023 (GLOBE NEWSWIRE) — Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One” or the “Company”), a clinical-stage biopharmaceutical company dedicated to developing and...

NEW YORK, Aug. 07, 2023 (GLOBE NEWSWIRE) — Cellectis S.A. (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today the release of the full report of the financial results for the second quarter 2023 (ended June 30, 2023) and filing of the corresponding 6-K with the SEC. Financial Results The interim condensed consolidated financial statements of Cellectis, have been prepared in accordance with International Financial Reporting Standards, as issued by the International Accounting Standards Board (“IFRS”). We present certain financial metrics broken out between our two reportable segments – Therapeutics and Plants – in the appendices of this Q2 2023 financial results press release. On January...

Strong Quarter Led by Higher Merchandise Contribution and Acquisitions RICHMOND, Va., Aug. 07, 2023 (GLOBE NEWSWIRE) — ARKO Corp. (Nasdaq: ARKO) (“ARKO” or the “Company”), a Fortune 500 company and one of the largest convenience store operators in the United States, today announced financial results for the quarter ended June 30, 2023. Second Quarter 2023 Key Highlights1Net income for the quarter was $14.5 million, compared to $31.8 million in the prior year quarter, primarily due to an approximately $15 million increase in depreciation and amortization expenses in connection with recent acquisitions, and favorable fair-value adjustments in the prior year quarter. Adjusted EBITDA for the quarter was $86.2 million, an increase of $7.2 million, as compared to $79.0 million in the prior year quarter. Same store merchandise sales...

ST. LOUIS, Aug. 07, 2023 (GLOBE NEWSWIRE) — BellRing Brands, Inc. (NYSE:BRBR) (“BellRing”), a holding company operating in the global convenient nutrition category, today reported results for the third fiscal quarter ended June 30, 2023. Highlights:Third quarter net sales of $445.9 million Operating profit of $76.0 million; net earnings available to common stockholders of $44.3 million and Adjusted EBITDA* of $86.9 million Generated $110.4 million in cash from operations Raised fiscal year 2023 net sales guidance to $1.63-$1.67 billion and Adjusted EBITDA* guidance to $330-$338 million*Adjusted EBITDA is a non-GAAP measure. For additional information regarding non-GAAP measures, see the related explanations presented under “Use of Non-GAAP Measures” later in this release. BellRing provides Adjusted EBITDA guidance only on a...

NEWARK, Del., Aug. 07, 2023 (GLOBE NEWSWIRE) — Artesian Resources Corporation (Nasdaq: ARTNA), a leading provider of water and wastewater services, and related services, on the Delmarva Peninsula, today announced second quarter and year-to-date results for 2023.Diluted net income per share decreased to $0.44 in the second quarter and to $0.84 year-to-date, compared to $0.53 and $1.01 in the comparative periods a year ago. Increased revenue by $0.2 million in the second quarter and $0.5 million year-to-date. Filed a request with the Delaware Public Service Commission on April 28th to implement increased water rates to support the on-going capital improvement program and increased costs of operations. Invested $32.3 million year-to-date in water and wastewater infrastructure. Raised $36.2 million in capital upon the sale of approximately...

– GAAP EARNINGS PER COMMON SHARE OF $1.87 – – DISTRIBUTABLE EARNINGS PER COMMON SHARE OF $0.36 – – DISTRIBUTABLE RETURN ON AVERAGE STOCKHOLDERS’ EQUITY OF 9.3% – NEW YORK, Aug. 07, 2023 (GLOBE NEWSWIRE) — Ready Capital Corporation (“Ready Capital” or the “Company”) (NYSE: RC), a multi-strategy real estate finance company that originates, acquires, finances, and services small-to-medium balance commercial (“SBC”) loans, today reported financial results for the quarter ended June 30, 2023. “The closing of the $867 million acquisition of Broadmark Realty Capital in the second quarter marks a significant milestone for Ready Capital,” said Thomas Capasse, Ready Capital’s Chairman and Chief Executive Officer. “Our increased scale and capabilities, significant liquidity and portfolio strength position...

REDUCES TOTAL DEBT BY $34.1 MILLION INCREASES 2023 FULL YEAR GUIDANCE Reduces Total Debt by $34.1 Million Increases 2023 Full Year Guidance BRENTWOOD, Tenn., Aug. 07, 2023 (GLOBE NEWSWIRE) — CoreCivic, Inc. (NYSE: CXW) (the Company) announced today its financial results for the second quarter of 2023. Damon T. Hininger, CoreCivic’s President and Chief Executive Officer, said, “Our second quarter financial results were better than our forecast and we are increasing our financial outlook for the year. We are increasing our financial outlook despite the challenging labor market, above average inflation and a higher interest rate environment. During the second quarter, we continued to execute on our long-term capital allocation strategy of reducing debt by repurchasing $21.0 million of our 8.25% Senior Notes that are scheduled...

– Petosemtamab granted Fast Track Designation for the treatment of patients with recurrent or metastatic head & neck squamous cell carcinoma – Phase 3 trial of petosemtamab monotherapy in previously treated (2L/3L) head and neck squamous cell carcinoma planned to initiate in mid-2024 – Zeno granted two Breakthrough Therapy Designations in NRG1 fusion (NRG1+) non-small cell lung and pancreatic cancer – Based on the Company’s current operating plan, existing cash, cash equivalents and marketable securities expected to fund Merus’ operations into 2026 UTRECHT, The Netherlands and CAMBRIDGE, Mass., Aug. 07, 2023 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced...

HOUSTON, Aug. 07, 2023 (GLOBE NEWSWIRE) — MRC Global Inc. (NYSE: MRC), the leading global distributor of pipe, valves, fittings and infrastructure products and services to diversified energy, industrial and gas utilities end-markets, today announced second quarter 2023 results. Net income attributable to common stockholders for the second quarter of 2023 was $18 million, or $0.21 per diluted share, as compared to the second quarter of 2022 net income of $8 million, or $0.09 per diluted share. Adjusted net income attributable to common stockholders for the second quarter of 2023 was $22 million, or $0.25 per diluted share, as compared to the second quarter of 2022 adjusted net income of $23 million, or $0.27 per diluted share. MRC Global’s second quarter 2023 gross profit was $175 million, or 20.1% of sales, as compared to the second quarter 2022 gross...